Alexander R Abbas

5PUBLICATIONS
67CO-AUTHORS
Molecular targetsMedical bacteriologyBiomedical fluid mechanicsCell development, proliferation and deathAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 07, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.

Rojo A Ratsimandresy, Emma Doran, Hart S Dengler

|Jan 12, 2022
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma.

Sarah E Headland, Hart S Dengler, Daqi Xu

|Aug 05, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.

Tianhe Sun, Zhiyu Huang, Wei-Ching Liang

|Mar 10, 2017
A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma.

Aarti Shikotra, David F Choy, Salman Siddiqui

Pageof 1